Eli Lilly & Co (NYSE:LLY) Shareholder Dodge & Cox Upped Its Position

May 17, 2018 - By Andrea Bass

Eli Lilly and Company (NYSE:LLY) Corporate LogoDuring 2017 Q4 the big money sentiment increased to 1.1. That’s change of 0.21, from 2017Q3’s 0.89. 42 investors sold all, 380 reduced holdings as LLY ratio increased. 346 rose stakes while 117 funds took stakes. Funds hold 827.08 million shares thus 0.09% less from 2017Q3’s 827.83 million shares. Huber Mgmt Limited Liability Company holds 411,460 shs. Bridges Invest Counsel holds 7,067 shs. Capital Intl Ca owns 23,392 shs or 0.37% of their US capital. Meritage Port Mgmt stated it has 0.04% of its capital in Eli Lilly and Company (NYSE:LLY). Glob X Mngmt Co Limited Co owns 18,323 shs. Jane Street Gru Llc owns 46,874 shs or 0.01% of their US capital. Blb&B Advsr Llc owns 8,049 shs or 0.1% of their US capital. Burt Wealth accumulated 4,130 shs. Connor Clark & Lunn Invest Management Limited accumulated 0.03% or 67,400 shs. Virginia-based Wilbanks Smith And Thomas Asset has invested 0.03% in Eli Lilly and Company (NYSE:LLY). Joel Isaacson & Ltd stated it has 0.05% in Eli Lilly and Company (NYSE:LLY). 11,333 are owned by Highland Ltd. Johnson Fin Gp Inc accumulated 0.05% or 5,015 shs. Voya Management Ltd Company stated it has 0.09% in Eli Lilly and Company (NYSE:LLY). Cwm Lc owns 1,248 shs.

LLY had 11 insider sales and 0 buys since December 11, 2017. This’s net activity of $48.49 million. LILLY ENDOWMENT INC also sold $17.64 million worth of Eli Lilly and Company (NYSE:LLY) shs. The insider Zakrowski Donald A sold 900 shs worth $72,981. Mahony Susan sold $1.81M worth of stock. On Friday, March 16 Shares for $237,600 were sold by Smiley Joshua L.

In Eli Lilly & Co (NYSE:LLY) was increased the holdings held by Dodge & Cox. The rise is 8.23% according to 2018Q1 Securities and Exchange regulatory form. 1.66M shares were bought by Dodge & Cox as Eli Lilly & Co (NYSE:LLY) stock declined 11.06% with the market. Dodge & Cox is holding 21.84M shares, compared to 20.18M last quarter. The reported value is $1.69B. $82.86B is the Eli Lilly & Co’s MC. The stock decreased 0.57% or $0.47 during the last trading session, hitting $81.18.Currently Eli Lilly and Company is downtrending after 10.19% change in last May 17, 2017. LLY has also 3.61 million shares volume. The stock underperformed the S&P500 by 21.74%.

$123.87B US longs are managed by Dodge & Cox. According to Securities and Exchange [filling] the stake in Hewlett Packard Enterprise Co () was reduced by 17.51M shares to 220.88M shares. They are valued at $3.87 billion in 2018Q1. It decreased Liberty Interactive Corp Qvc G (NASDAQ:QVCA) position by 642,100 shares to 33.94 million shares, and cut its Te Connectivity Ltd (NYSE:TEL) stake.

Dodge & Cox is a California-based institutional investor with more than $224.00 billion AUM in October, 2014. This fund invests only a small percentage of its assets in equities and options. Dodge & Cox is the 15th largest institutional investor in our database. Taken from Dodge & latest Adv, the fund reported to have 205 full and part-time employees. Among which 85 performing investment advisory and research functions. The institutional investor had more than 500 clients.

Eli Lilly and Company (NYSE:LLY) Ratings Coverage

A total of 10 analysts rate Eli Lilly (NYSE:LLY) as follows: 4 “Buy”, 5 “Hold” and 1 “Sell”. Тherefore 40% are bullish. (NYSE:LLY) has 17 ratings reports on 17 May 2018 according to StockzIntelligence. On Thursday, February 1 Bank of America maintained Eli Lilly and Company (NYSE:LLY) rating. Bank of America has “Neutral” rating and $86 target. On Friday, January 5 the firm has “Buy” rating by Argus Research given. The stock rating was maintained by Jefferies with “Buy” on Friday, March 23. On Monday, January 22 the stock of Eli Lilly and Company (NYSE:LLY) has “Underperform” rating given by Credit Suisse. On Thursday, February 1 the firm has “Hold” rating given by Leerink Swann. On Wednesday, December 13 the stock of Eli Lilly and Company (NYSE:LLY) earned “Hold” rating by Leerink Swann. On Tuesday, January 16 Jefferies maintained Eli Lilly and Company (NYSE:LLY) with “Buy” rating. On Wednesday, April 25 the firm earned “Market Perform” rating by BMO Capital Markets. On Friday, April 13 Jefferies maintained Eli Lilly and Company (NYSE:LLY) rating. Jefferies has “Buy” rating and $9000 target. On Monday, February 26 Jefferies maintained Eli Lilly and Company (NYSE:LLY) with “Buy” rating.

Eli Lilly and Company discovers, develops, makes, and markets pharmaceutical products worldwide.The firm is worth $82.86 billion. It operates through two divisions, Human Pharmaceutical Products and Animal Health Products.Currently it has negative earnings. The firm offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.

Eli Lilly and Company (NYSE:LLY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: